Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
International Journal of Clinical Practice. Supplement
|
October 12, 2001
The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes: point
S Haffner
Diabetes, Obesity & Metabolism
|
November 18, 2003
Metabolic syndrome - a new risk factor of coronary heart disease?
S Haffner, H B Cassells
Hypertension (Dallas, Tex. : 1979)
|
June 1, 1994
Glucose and insulin levels during diuretic therapy in hypertensive men
D Siegel, P Saliba, S Haffner
Deutsche Medizinische Wochenschrift (1946)
|
May 9, 2002
[Adverse drug reactions--case report]
S Haffner, H Lapp, P A Thürmann
Deutsche Medizinische Wochenschrift (1946)
|
May 9, 2002
[Adverse drug reactions. QT-prolongation and torsade-de-pointes arrhythmias]
S Haffner, H Lapp, P A Thürmann
International Journal of Clinical Pharmacology and Therapeutics
|
October 3, 2002
A review of the pharmacological and psychopharmacological aspects of smoking and smoking cessation in psychiatric patients
K O Haustein, S Haffner, B G Woodcock
Advances in Therapy
|
May 29, 2007
Initial clinical experience with the trabecular micro-bypass stent in patients with glaucoma
Detlev Spiegel, Wolfgang Wetzel, David S Haffner, et al.
Clinical Cardiology
|
May 1, 1995
Effect of simvastatin on Lp(a) concentrations
S Haffner, T Orchard, E Stein, et al.
Diabetes
|
December 1, 1992
The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents
G Gulli, E Ferrannini, M Stern, et al.
Clinical Science (London, England : 1979)
|
June 1, 1997
Serum leptin and short-term regulation of eating in obese women
L Karhunen, S Haffner, R Lappalainen, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
International Journal of Clinical Practice. Supplement
|
October 12, 2001
The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes: point
S Haffner
Diabetes, Obesity & Metabolism
|
November 18, 2003
Metabolic syndrome - a new risk factor of coronary heart disease?
S Haffner, H B Cassells
Hypertension (Dallas, Tex. : 1979)
|
June 1, 1994
Glucose and insulin levels during diuretic therapy in hypertensive men
D Siegel, P Saliba, S Haffner
Deutsche Medizinische Wochenschrift (1946)
|
May 9, 2002
[Adverse drug reactions--case report]
S Haffner, H Lapp, P A Thürmann
Deutsche Medizinische Wochenschrift (1946)
|
May 9, 2002
[Adverse drug reactions. QT-prolongation and torsade-de-pointes arrhythmias]
S Haffner, H Lapp, P A Thürmann
International Journal of Clinical Pharmacology and Therapeutics
|
October 3, 2002
A review of the pharmacological and psychopharmacological aspects of smoking and smoking cessation in psychiatric patients
K O Haustein, S Haffner, B G Woodcock
Advances in Therapy
|
May 29, 2007
Initial clinical experience with the trabecular micro-bypass stent in patients with glaucoma
Detlev Spiegel, Wolfgang Wetzel, David S Haffner, et al.
Clinical Cardiology
|
May 1, 1995
Effect of simvastatin on Lp(a) concentrations
S Haffner, T Orchard, E Stein, et al.
Diabetes
|
December 1, 1992
The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents
G Gulli, E Ferrannini, M Stern, et al.
Clinical Science (London, England : 1979)
|
June 1, 1997
Serum leptin and short-term regulation of eating in obese women
L Karhunen, S Haffner, R Lappalainen, et al.
Page
of 5